Evaluating Patient Experiences in Skin Care Clinical Studies
Launched by POWER LIFE SCIENCES INC. · Feb 10, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Evaluating Patient Experiences in Skin Care Clinical Studies," is designed to study new skin care products and treatments. The main goal is to understand how different groups of people, especially those who are often underrepresented in research, experience these trials. Researchers want to find out how many people complete the study versus how many withdraw, and they will look for patterns based on different characteristics like age and gender. This information can help improve future skin care studies.
To participate in this trial, you need to be at least 18 years old and willing to follow the treatment and follow-up schedule. You’ll also need to provide written consent, which means you agree to take part in the study. However, pregnant women, those planning to become pregnant, or those who are breastfeeding cannot join. Participants should be able to report their experiences electronically. If you choose to participate, you can expect to contribute valuable insights that may lead to better skin care options for everyone in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient is at least 18 years of age
- • Patient is able and willing to comply with the treatment/follow-up schedule and requirements
- • Patient must provide written informed consent
- Exclusion Criteria:
- • Women who are pregnant, intend to become pregnant, or are lactating
- • Inability to perform regular electronic reporting
- • Participants who are vulnerable to any intervention
About Power Life Sciences Inc.
Power Life Sciences Inc. is a forward-thinking clinical trial sponsor dedicated to advancing innovative therapeutic solutions across various medical disciplines. With a strong emphasis on scientific rigor and patient-centered approaches, the organization collaborates with leading researchers and healthcare professionals to design and execute clinical trials that prioritize safety, efficacy, and compliance. Power Life Sciences Inc. leverages cutting-edge technology and data analytics to streamline trial processes, enhance participant engagement, and accelerate the development of life-changing treatments, ultimately aiming to improve patient outcomes and contribute to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Michael B Gill
Study Director
Power Life Sciences Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials